Beasley, Allen, Crow, Methvin, Portis & Miles, P.C.

Five years after the food and Drug Administration first alerted medical professionals about a possible link between gadolinium-based contrast agents (GBCAs) and a serious kidney dysfunction known as Nephrogenic Systemic Fibrosis (NSF), the agency this week announced it is requiring changes to the drug’s professional labeling in an effort to minimize the risk. The agency noted that NSF after GBCAs has not been reported in patients with normal kidney function, and that patients at greatest risk for developing the condition after GBCAs are those with impaired elimination of the drug, including patients with acute kidney injury or chronic, severe kidney disease.

Read the rest of this entry »

Today Beasley Allen filed two complaints in multidistrict litigation (MDL) on behalf of clients injured by gadolinium.

Gadolinium is linked to adverse health effects on patients with renal insufficiency or kidney failure, including Nephrogenic Systemic Fibrosis (NSF), which causes fibrosis of the skin and connective tissues and scarring of organs including lungs, heart, and liver and may lead to death.

Read the rest of this entry »

Injecting a toxic liquid metal such as gadolinium into the bloodstream may seem like a procedure from a sci-fi horror movie, but it is a common, every day occurrence in medical centers throughout the country.

Read the rest of this entry »

Another Nephrogenic Systemic Fibrosis (NSF) study has tied the debilitating condition to Gadolinium contrast agents used in Magnetic Resonance Imaging (MRI). This latest NSF research was conducted by the Centers for Disease Control (CDC), which examined a cluster of NSF patients at one unidentified St. Louis Missouri Hospital. The CDC found that the exposure to Gadolinium contrast dyes during MRI was independently associated with the development of NSF.

Read the rest of this entry »

Gadolinium based MRI contrast agents have been implicated in at least 1,000 cases of a debilitating disorder called Nephrogenic Systemic Fibrosis/ Nephrogenic Fibrosing Dermopathy (NSF/NSD) around the world. This horrible disease causes a buildup of collagen in tissues, leading to a severe thickening and hardening of the skin. NSF/NSD can completely immobilize patients, and in severe cases it can lead to death.

Read the rest of this entry »

A growing number of people are becoming afflicted with an incurable, man-made disease that is related to a common medical procedure performed every single day in this country, a KCRA 3 investigation has found. Sarah Fracella is one the victims.

Read the rest of this entry »

If she knew then what she knows now, Sarah Fracella would not have undergone an MRI. “I don’t think there’s been a day in the last, probably, two years that’s gone by that I haven’t cried at least once about this,” said Fracella, 38, of Santa Barbara, whose skin is hardening painfully into something that looks startlingly like marble.

Read the rest of this entry »

Gadolinium based contrast agents used during MRIs, are known to be associated with the onset of Nephrogenic Systemic Fibrosis/ Nephrogenic Fibrosing Dermopathy (NSF/NSD) in patients with pre-existing kidney disease.

Read the rest of this entry »

An elderly man has sued several major health companies, claiming the dyes used to scan his failing kidneys caused a rare, painful and incurable disease. Peter Gerber, 72, of San Rafael, contends that injections of dyes containing the heavy metal gadolinium caused him to develop nephrogenic systemic fibrosis, or NSF. Also known as nephrogenic fibrosing demopathy, the disease can thicken the skin, stiffen joints, restrict movement and potentially lead to death if it affects internal organs.

Read the rest of this entry »

Nephrogenic systemic fibrosis (NSF) is a new fibrotic skin disease entity that was first recognized in 1997 in 15 patients receiving hemodialysis.

Read the rest of this entry »